Cargando…
Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review
The main treatment of MM metastases are systemic therapies, surgery, limb perfusion, and intralesional talimogene laherparepvec. Electrochemotherapy (ECT) is potentially useful also due to the high response rates recorded in cancers of any histology. No randomized studies comparing ECT with other lo...
Autores principales: | Ferioli, Martina, Lancellotta, Valentina, Perrone, Anna Myriam, Arcelli, Alessandra, Galuppi, Andrea, Strigari, Lidia, Buwenge, Milly, De Terlizzi, Francesca, Cammelli, Silvia, Iezzi, Roberto, De Iaco, Pierandrea, Tagliaferri, Luca, Morganti, Alessio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474499/ https://www.ncbi.nlm.nih.gov/pubmed/35869314 http://dx.doi.org/10.1007/s10585-022-10180-9 |
Ejemplares similares
-
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control
por: Ferioli, Martina, et al.
Publicado: (2023) -
Palliative Electrochemotherapy in Vulvar Carcinoma: Preliminary Results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) Multicenter Study
por: Perrone, Anna Myriam, et al.
Publicado: (2019) -
Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review
por: Zamagni, Alice, et al.
Publicado: (2022) -
Quality of Life with Vulvar Carcinoma Treated with Palliative Electrochemotherapy: The ELECHTRA (ELEctroCHemoTherapy vulvaR cAncer) Study
por: Perrone, Anna Myriam, et al.
Publicado: (2021) -
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study)
por: Ferioli, Martina, et al.
Publicado: (2023)